Detalhe da pesquisa
1.
Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction.
N Engl J Med
; 390(17): 1560-1571, 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38587254
2.
Empagliflozin after Acute Myocardial Infarction.
N Engl J Med
; 390(16): 1455-1466, 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38587237
3.
Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia.
N Engl J Med
; 389(26): 2446-2456, 2023 Dec 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37952133
4.
Relating Lipoprotein(a) Concentrations to Cardiovascular Event Risk After Acute Coronary Syndrome: A Comparison of 3 Tests.
Circulation
; 149(3): 192-203, 2024 01 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37632469
5.
Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights From the EMPACT-MI Trial.
Circulation
; 149(21): 1627-1638, 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38581389
6.
Survival After Invasive or Conservative Management of Stable Coronary Disease.
Circulation
; 147(1): 8-19, 2023 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36335918
7.
Optimizing post-acute coronary syndrome (ACS) dyslipidemia management: Insights from the North American Acute Coronary Syndrome ACS Reflective III.
Cardiology
; 2024 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38290490
8.
Transiently achieved very low LDL-cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction: the ODYSSEY OUTCOMES trial.
Eur Heart J
; 2023 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36879424
9.
Comprehensive Quality-of-Life Outcomes With Invasive Versus Conservative Management of Chronic Coronary Disease in ISCHEMIA.
Circulation
; 145(17): 1294-1307, 2022 04 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35259918
10.
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.
Circulation
; 146(9): 657-672, 2022 08 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35770629
11.
Initial Invasive or Conservative Strategy for Stable Coronary Disease.
N Engl J Med
; 382(15): 1395-1407, 2020 04 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32227755
12.
Rationale and design for the myocardial ischemia and transfusion (MINT) randomized clinical trial.
Am Heart J
; 257: 120-129, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36417955
13.
Effect of alirocumab on cataracts in patients with acute coronary syndromes.
BMC Ophthalmol
; 23(1): 279, 2023 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37328736
14.
Digital Tool-Assisted Hospitalization Detection in the Tailored Antiplatelet Initiation to Lessen Outcomes due to Decreased Clopidogrel Response After Percutaneous Coronary Intervention Study Compared to Traditional Site-Coordinator Ascertainment: Intervention Study.
J Med Internet Res
; 25: e47475, 2023 11 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37948098
15.
Alirocumab after acute coronary syndrome in patients with a history of heart failure.
Eur Heart J
; 43(16): 1554-1565, 2022 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34922353
16.
Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial.
Circulation
; 144(16): 1295-1307, 2021 10 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34459214
17.
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective: 2021 Update.
Circulation
; 143(6): 583-596, 2021 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33555916
18.
Clinical Efficacy and Safety of Alirocumab After Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score-Matched Analysis of the ODYSSEY OUTCOMES Trial.
Circulation
; 143(11): 1109-1122, 2021 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33438437
19.
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation.
N Engl J Med
; 380(16): 1509-1524, 2019 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30883055
20.
Associated factors and clinical outcomes in mechanical circulatory support use in patients undergoing high risk on-pump cardiac surgery: Insights from the LEVO-CTS trial.
Am Heart J
; 248: 35-41, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35263653